XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.2
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2019
Stockholders' Equity Note [Abstract]  
Schedule of Compensation Cost on Net Earnings
The Company’s results for the three and six months ended June 30, 2019 and 2018 reflected the following stock-based compensation cost, and such compensation cost had the following effects on net earnings:
 
 
Increase/(Decrease) for the
Three Months Ended June 30,
 
Increase/(Decrease) for the
Six Months Ended June 30,
 
 
2019
 
2018
 
2019
 
2018
Cost of sales
 
$
288

 
$
242

 
$
576

 
$
487

Operating expenses
 
1,703

 
1,424

 
3,046

 
2,972

Net earnings
 
(1,533
)
 
(1,280
)
 
(2,791
)
 
(2,657
)
Schedule of Stock Option Activity
Option activity for the six months ended June 30, 2019 and 2018 is summarized below:

For the six months ended
June 30, 2019
 
Shares (000s)
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 2018
 
887

 
$
61.59

 
$
16,192

 
 
Granted
 
187

 
84.29

 
 
 
 
Exercised
 
(33
)
 
55.88

 
 
 
 
Forfeited
 
(7
)
 
80.59

 
 
 
 
Canceled
 
(4
)
 
70.90

 
 
 
 
Outstanding as of June 30, 2019
 
1,030

 
$
65.74

 
$
35,242

 
6.5
 
 
 
 
 
 
 
 
 
Exercisable as of June 30, 2019
 
658

 
$
56.77

 
$
28,413

 
5.2

For the six months ended
June 30, 2018
 
Shares (000s)
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Weighted
Average
Remaining
Contractual
Term
Outstanding as of December 31, 2017
 
946

 
$
55.44

 
$
24,714

 
 
Granted
 
148

 
74.57

 
 
 
 
Exercised
 
(152
)
 
43.32

 
 
 
 
Forfeited
 
(2
)
 
75.44

 
 
 
 
Canceled
 
(1
)
 
25.39

 
 
 
 
Outstanding as of June 30, 2018
 
939

 
$
60.42

 
$
35,409

 
6.6
 
 
 
 
 
 
 
 
 
Exercisable as of June 30, 2018
 
534

 
$
49.19

 
$
26,142

 
5.3

Schedule of Other Information Pertaining to Stock Option Activity
Other information pertaining to option activity during the three and six months ended June 30, 2019 and 2018 was as follows:
 
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
 
2019
 
2018
 
2019
 
2018
Weighted-average fair value of options granted
 
$
19.18

 
$

 
$
18.27

 
$
18.62

Total intrinsic value of stock options exercised ($000s)
 
$
997

 
$
5,375

 
$
1,299

 
$
7,200


Schedule of Non-vested Restricted Stock Activity
Non-vested restricted stock activity for the six months ended June 30, 2019 and 2018 is summarized below:
Six Months ended June 30, 2019
 
Shares (000s)
 
Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 31, 2018
 
79

 
$
72.75

Granted
 
67

 
84.44

Vested
 
(8
)
 
58.52

Forfeited
 
(1
)
 
76.73

Non-vested balance as of June 30, 2019
 
137

 
$
79.31

Six months ended June 30, 2018
 
Shares (000s)
 
Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 31, 2017
 
66

 
$
65.66

Granted
 
37

 
75.19

Vested
 
(17
)
 
57.65

Forfeited
 

 

Non-vested balance as of June 30, 2018
 
86

 
$
71.40


Schedule of Non-vested Performance Share Activity
Non-vested performance share activity for the six months ended June 30, 2019 and 2018 is summarized below:
Six Months ended June 30, 2019
 
Shares (000s)
 
Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 31, 2018
 
53

 
$
75.61

Granted
 
33

 
81.79

Vested
 
(9
)
 
65.64

Forfeited
 
(7
)
 
60.85

Non-vested balance as of June 30, 2019
 
70

 
$
81.26

Six months ended June 30, 2018
 
Shares (000s)
 
Weighted
Average Grant
Date Fair
Value
Non-vested balance as of December 31, 2017
 
39

 
$
72.62

Granted
 
32

 
71.27

Vested
 
(15
)
 
58.78

Forfeited
 

 

Non-vested balance as of June 30, 2018
 
56

 
$
75.47